A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus
Epstein-Barr virus (EBV) is tightly associated with certain human cancers, but there is as yet no specific treatment against EBV-related diseases. The EBV-encoded EBNA1 protein is essential to maintain viral episomes and for viral persistence. As such, EBNA1 is expressed in all EBV-infected cells, a...
Saved in:
Main Authors: | Cécile Voisset (Author), Chrysoula Daskalogianni (Author), Marie-Astrid Contesse (Author), Anne Mazars (Author), Hratch Arbach (Author), Marie Le Cann (Author), Flavie Soubigou (Author), Sébastien Apcher (Author), Robin Fåhraeus (Author), Marc Blondel (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2014-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epstein-Barr Virus New Trends
Published: (2021) -
Epstein-Barr virus and skin
by: Martin Sangueza-Acosta, et al.
Published: (2018) -
Soro-epidemiologia do virus de Epstein-Barr (VEB) The seroepidemiology of the Epstein-Barr vírus (EBV)
by: Claudio Sergio Pannuti
Published: (1981) -
Macular Amyloidosis and Epstein-Barr Virus
by: Yalda Nahidi, et al.
Published: (2016) -
Epstein-Barr Virus Neurologic Complications
by: J. Gordon Millichap
Published: (2015)